POINT Biopharma
PNT
$12.50
Share price
0.00%
Change (1 day)
84.37%
Change (1 year)
Categories
POINT Biopharma (PNT) - P/B ratio
P/B ratio as of May 2024 : 3.14
According to POINT Biopharma's latest financial reports the company has a price-to-book ratio of 3.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
POINT Biopharma - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.14 | 98.56% |
| 2022-12-31 | 1.58 | -20.02% |
| 2021-12-31 | 1.98 | |
| 2020-12-31 | N/A |